Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Prospective, Open-label, Multicenter, Pharmacoepidemiological Study to Determine Predictors of Clinical Outcomes in Haemodialysis Patients With Anaemia Treated With Biosimilar Epoetin Alfa

NCT01121237 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT01121237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01121237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Prospective, Open-label, Multicenter, Pharmacoepidemiological Study to Determine Predictors of Clinical Outcomes in Haemodialysis Patients With Anaemia Treated With Biosimilar Epoetin Alfa
Lead sponsor
Sandoz
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
November 30, 2014
Enrollment
2,086 (actual)
Sites
95

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia, chronic kidney disease, end-stage renal disease